Key facts
- It has raised $5.0M; the latest was PE Growth/Expansion ($5.0M) in Apr 2026.
- Notable investors include Blue Heron Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Remission Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Remission Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Remission Medical
Provider of virtual rheumatology clinic care services intended to connect board-certified, state-licensed rheumatologists. The company specializes in autoimmune inflammatory conditions that offer HIPAA-compliant video visits, accurate diagnosis is made and treatment begins, the more likely a patient is to avoid life-altering surgeries such as total joint replacement, thereby enabling clients to get relief from pain due to their autoimmune inflammatory conditions through a virtual-first clinic that offers end-to-end support.
- Sector
- Healthcare
- HQ
- Richmond, VA, United States
- Founded
- 2021
- Employees
- 25
- Website
- remissionmedical.com/
- Ownership
- Privately Held (backing)
Remission Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Remission Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Remission Medical in its N-PORT filings yet. We sweep new filings monthly.